A

Alejandro Pérez Cabeza

Centro de Investigación en Red en Enfermedades Cardiovasculares

4 papers and 23 citations.

4Publications

23Total Citations

Top publicationsby citations

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

María Asunción Esteve‐Pastor, Francisco Marı́n, Román Freixa‐Pamias et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022

Cited by 16

Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

Manuel Anguita Sánchez, Marcelo Sanmartı́n, Francisco Marı́n et al.|Cardiology Journal|2022

Cited by 3

Recomendaciones de expertos en la mejora de la prevención efectiva del ictus isquémico en la fibrilación auricular no valvular: papel del rivaroxabán

Alejandro Pérez Cabeza, Jaime Masjuán, Jaime Nevado Portero et al.|Revista Española de Cardiología Suplementos|2020

Cited by 2

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

Francisco Marı́n, Manuel Anguita Sánchez, Marcelo Sanmartı́n et al.|Journal of Comparative Effectiveness Research|2023

Cited by 2

Indexing the rest of 4 publications…